Targeted therapy in head and neck cancer

Related Experiment Video

Updated: Jun 1, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Chiara Bianchini1, Andrea Ciorba, Stefano Pelucchi

  • 1ENT Department, University Hospital of Ferrara, Ferrara, Italy. chiara.bianchini@unife.it

Tumori
|May 28, 2011
PubMed
Abstract

Insights

Molecular targeting offers new strategies for head and neck cancers by specifically damaging tumor cells while preserving healthy tissues. This approach shows promise for primary and adjuvant treatments, addressing challenges like treatment resistance and recurrence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Head and Neck Cancer Research

Background:

  • Cancer initiation and progression involve complex molecular mechanisms.
  • Treatment resistance and recurrence are significant challenges in aggressive head and neck tumors.
  • Conventional treatments for solid tumors, including head and neck cancers, face limitations.

Purpose of the Study:

  • To review recent advances in understanding molecular mechanisms of head and neck cancer.
  • To discuss the development of targeted cellular strategies for head and neck cancer treatment.
  • To explore the potential of molecular targeted therapy in solid tumors.

Main Methods:

  • Systematic review of the PubMed database.
  • Analysis of current literature on molecular mechanisms in head and neck cancer.
  • Evaluation of targeted cellular strategies and molecular targeted therapy.

Main Results:

  • Molecular targeted therapy is emerging in clinical practice for solid tumors.
  • Antibodies targeting tumor-specific cells are used in some hematologic malignancies.
  • Understanding molecular mechanisms is key to developing new therapeutic strategies.

Conclusions:

  • Molecular targeting can specifically damage cancer cells while sparing healthy tissues.
  • This approach offers new perspectives for primary and adjuvant treatment of head and neck tumors.
  • Targeted therapies hold promise for overcoming treatment resistance and improving outcomes.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...